Allspring Global Investments’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
Other funds holding FOLD
VCM
PCM
VPM
GCL
Allspring Global Investments's FOLD Position: Q1 2026 in Review
Allspring Global Investments sold out of Amicus Therapeutics (FOLD) in Q1 2026, closing a stake of 27,062 shares — an estimated $386K sold.
Allspring Global Investments first reported a position in FOLD in Q4 2021 and held it in 17 quarters. The position peaked at $1.83M in Q4 2021. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.
- Allspring Global Investments reported no remaining Amicus Therapeutics position as of Q1 2026 after selling out during the quarter.
- Allspring Global Investments sold 27,062 Amicus Therapeutics shares in Q1 2026, an estimated $386K.
- Allspring Global Investments first reported a position in Amicus Therapeutics in Q4 2021 and held it in 17 quarters.
- Allspring Global Investments's Amicus Therapeutics position peaked at $1.83M in Q4 2021.
- 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.
Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.